Dexcom ’s board has confirmed that President and Chief Operating Officer Jacob S. Leach will assume the roles of President, Chief Executive Officer and director effective January 1, 2026, following ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
In a report released on December 16, William Plovanic from Canaccord Genuity maintained a Buy rating on Dexcom, with a price target of $99.00. The company’s shares closed yesterday at $66.37.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback